Long-Term Outcomes of Selexipag in Schistosomiasis-Associated Pulmonary Arterial Hypertension
NCT07453030
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Arterial Hypertension (PAH)
Sponsor
Caio Júlio César dos Santos Fernandes